INSM1 has been proposed not only as a useful adjunct but also as a potential first-line marker for confirming neuroendocrine differentiation in pulmonary neuroendocrine neoplasms, particularly SCLC and LCNEC [11,14]. Here, INSM1 is linked to lung neuroendocrine neoplasm.